Aller au contenu principal
Accès ouvert déclaré 2025 article

Feasibility and Acceptability of SARS-CoV-2 Antigen Rapid Diagnostic Testing in High-Risk Markets and Trade Hubs in Kampala, Uganda

0Citations signalées — pas une note de qualité
3Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Congregate settings are high-risk places for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, making strategies that rely solely on hospital-based testing ineffective in curbing transmissions. We therefore evaluated the feasibility, utility, and acceptability of testing with SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) in markets and trade hubs in Kampala, Uganda. Between June and September 2022, we conducted a prospective operational research study in five divisions of Kampala. Four rounds of monthly cross-sectional surveys were conducted at one market and one trading hub per division, resulting in a total of 13,086 volunteers tested. Females were more likely than males to be tested (54% versus 46%), which aligns with sex-based differences in health-seeking behavior. More tests were conducted in markets (68%) compared with trade centers (32%). Several interventions increased overall demand for testing, including 1) awareness campaigns and mobilization activities; 2) the movement of teams across congregate settings; 3) the optimization of workflow; and 4) testing traders at their workstations. The overall positivity rate during the 4 months was 0.6% (78/13,086). There was a steady decline in positivity rates by month, aligning with the trend observed at the national level. Of the 78 positive index cases identified, 105 contacts were traced; 71% of these could be reached. None of the positive patients successfully self-isolated for the 14 days specified in national guidelines. Nevertheless, this study demonstrates that testing market dwellers with Ag-RDTs is not only acceptable and feasible in Uganda but also an important public health tool for the timely detection of SARS-CoV-2. This approach may be replicated in similar settings.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Feasibility and Acceptability of SARS-CoV-2 Antigen Rapid Diagnostic Testing in High-Risk Markets and Trade Hubs in Kampala, Uganda
Date Crossref
01/04/2025
Éditeur
American Society of Tropical Medicine and Hygiene
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 epidemiological studies

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.